A Clinical Study of an Investigational Drug for the Treatment of Major Depressive Episode Associated With Bipolar I Disorder.
Clinical trial NCT05169710 · TERMINATED
Trial details
- NCT number
- NCT05169710
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-21
- Primary completion
- 2023-10-18
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.